Traded Oct 29, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Oct 2, 2025 · Filed Oct 7, 2025
The CEO of Vistra sold $4.36M of Vistra shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$4,360,966
Shares × reported transaction price
56 days after results of Aug 7, 2025, 35 days before results of Nov 6, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $202.65 on Oct 2, 2025, 107% above its 52-week low and 7% below its high, after a 5% rise over the previous 30 trading days
52-week range $98.07 (Apr 4, 2025) to $217.92 (Sep 22, 2025), 87% of the way up, from 250 adjusted closes. 30 trading days earlier: $192.91 on Aug 20, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.0% | −1.0% | +4.0% |
| 30 days | −7.5% | +0.2% | −7.7% |
| 90 days | −18.4% | +2.8% | −21.2% |
| 180 days | −24.1% | −1.5% | −22.5% |
Past results only. Not a forecast.
Traded Oct 29, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
James A Burke (President and CEO) sold ~$1.85M of Vistra Corp.
Scheduled in advanceTraded Oct 29, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.